EZH2 (Q15910) variants and mutations
EZH2 (also known as Q15910) is a human protein-coding gene encoding a histone-lysine N-methyltransferase protein. It deposits repressive H3K27 trimethylation through Polycomb repressive complex 2 and thereby maintains cell-identity and developmental gene silencing. Activating variants drive some germinal-center lymphomas, while germline gain- or loss-of-function variants can cause overgrowth or developmental syndromes. This analysis covers 850 EZH2 variants and mutations. Of these, 42% have computational variant effect predictions. Disease context includes Weaver syndrome, diffuse large B-cell lymphoma, and neurodegenerative disease. Example EZH2 variants include M1?, G2C, and G2S.
Variant analysis overview
- Gene: EZH2
- Protein: Q15910
- UniProt accession: Q15910
- Organism: Homo sapiens
- Variants analyzed: 850
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 733 unspecified-consequence records; 3 stop lost; 37 synonymous variants; 59 missense variants; 1 stop-gained variants; 4 frameshift variants; 1 in-frame insertions; 4 splice-region variants; 8 substitution
- Prediction scores: 361 variants have prediction scores (42% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Weaver syndrome, diffuse large B-cell lymphoma, neurodegenerative disease, follicular lymphoma, viral infectious disease, melanoma, breast carcinoma, lymphoma, acute myeloid leukemia, neoplasm, non-Hodgkin lymphoma, cancer.
Protein structure and variant hotspots
- Protein features: 2 domains; 9 post-translational modification sites.
- Structural context: 356 variants have structural context.
- PTM context: 4 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable EZH2 variants
Examples include M1?, G2C, G2S, Q3L, T4I, T4P, G5W, K6M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV57463
- G2C (p.Gly2Cys), cosmic curated COSV10023
- G2S (p.Gly2Ser), cosmic curated COSV57446, TOPMed rs1814403036, REVEL 0.39, CADD 22.80
- Q3L (p.Gln3Leu), cosmic curated COSV57459, TOPMed rs1035066688, gnomAD rs1035066688, REVEL 0.34, CADD 20.60
- T4I (p.Thr4Ile), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; moderate impact.
- T4P (p.Thr4Pro), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; moderate impact.
- G5W (p.Gly5Trp), cosmic curated COSV57455
- K6M (p.Lys6Met), NCI-TCGA Cosmic COSV5745, cosmic curated COSV57451, Variant assessed as somatic; moderate impact.
- S8F (p.Ser8Phe), cosmic curated COSV57460
- G11V (p.Gly11Val), rs1400051032, ClinGen CA369708573, ClinVar RCV003230047, AlphaMissense 0.63, MetaLR 0.82, Uncertain significance, not provided
- V13A (p.Val13Ala), rs2129485390, ClinGen CA369708562, cosmic curated COSV57449, ClinVar RCV001768799, AlphaMissense 0.19, MetaLR 0.46, Uncertain significance, not provided
- W15* (p.Trp15Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- W15L (p.Trp15Leu), rs760133156, ClinGen CA369708548, ClinVar RCV001270773, ClinVar RCV005629942, AlphaMissense 0.94, MetaLR 0.94, Uncertain significance, not provided; Weaver syndrome
- R16Q (p.Arg16Gln), cosmic curated COSV57449, TOPMed rs1814390527, REVEL 0.40, CADD 23.00
- R16W (p.Arg16Trp), cosmic curated COSV57448, gnomAD rs1814391391, REVEL 0.61, CADD 26.10
- K17N (p.Lys17Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R18C (p.Arg18Cys), rs771352080, NCI-TCGA Cosmic COSV5745, cosmic curated COSV57452, ExAC rs771352080, REVEL 0.59, CADD 28.80, Variant assessed as somatic; moderate impact.
- R18H (p.Arg18His), cosmic curated COSV10023, Ensembl rs2129485381, REVEL 0.47, CADD 22.90, Uncertain significance, Weaver syndrome; not provided
- S21* (p.Ser21Ter), cosmic curated COSV10884
- E22* (p.Glu22Ter), cosmic curated COSV10966
- R25* (p.Arg25Ter), rs1169410711, ClinGen CA369708481, NCI-TCGA Cosmic COSV5744, NCI-TCGA Cosmic COSV5746, Uncertain significance
- R25Q (p.Arg25Gln), rs2129485373, ClinGen CA369708479, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57462, AlphaMissense 0.96, MetaLR 0.67, Uncertain significance, Weaver syndrome
- L26P (p.Leu26Pro), cosmic curated COSV57448
- R27* (p.Arg27Ter), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; high impact.
- Q28* (p.Gln28Ter), cosmic curated COSV57458
- Q28H (p.Gln28His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q28R (p.Gln28Arg), cosmic curated COSV57462
- R34* (p.Arg34Ter), NCI-TCGA Cosmic COSV5745, cosmic curated COSV57451, Variant assessed as somatic; high impact.
- R34L (p.Arg34Leu), NCI-TCGA Cosmic COSV5745, cosmic curated COSV57453, Variant assessed as somatic; moderate impact.
- R34Q (p.Arg34Gln), rs2129485367, ClinGen CA369708419, cosmic curated COSV10588, ClinVar RCV002275774, REVEL 0.56, CADD 25.00, Uncertain significance, Inborn genetic diseases; not provided
- D36N (p.Asp36Asn), cosmic curated COSV10520, Uncertain significance, not provided
- E37A (p.Glu37Ala), rs1291033053, TOPMed rs1291033053, AlphaMissense 0.81, MetaLR 0.72, Variant assessed as somatic; moderate impact.
- K39E (p.Lys39Glu), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; moderate impact.
- S40C (p.Ser40Cys), cosmic curated COSV57454
- S40I (p.Ser40Ile), NCI-TCGA TCGA novel, Ensembl rs2129485066, REVEL 0.51, CADD 23.10, Variant assessed as somatic; moderate impact.
- M41I (p.Met41Ile), cosmic curated COSV10441, Ensembl rs2129485059, REVEL 0.42, CADD 23.10
- S43I (p.Ser43Ile), NCI-TCGA Cosmic COSV5744, cosmic curated COSV57447, Ensembl rs2129485050, Variant assessed as somatic; moderate impact.
- N45D (p.Asn45Asp), cosmic curated COSV10610
- R46H (p.Arg46His), rs1333628386, cosmic curated COSV57460, ClinVar RCV004586216, ClinVar RCV006613377, REVEL 0.74, CADD 25.10, Uncertain significance, Weaver syndrome; not specified
- R46L (p.Arg46Leu), cosmic curated COSV10942, TOPMed rs1333628386, gnomAD rs1333628386, REVEL 0.65, CADD 24.70, Uncertain significance
- I49V (p.Ile49Val), cosmic curated COSV57462
- R52I (p.Arg52Ile), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; moderate impact.
- R52K (p.Arg52Lys), rs752284693, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, REVEL 0.34, CADD 20.60, Variant assessed as somatic; moderate impact.
- T53M (p.Thr53Met), rs768812143, ClinGen CA369708274, cosmic curated COSV57452, ClinVar RCV000523469, REVEL 0.50, CADD 24.60, Conflicting interpretations, not provided; Weaver syndrome
- E54K (p.Glu54Lys), cosmic curated COSV57449, Ensembl rs2129485016
- I55M (p.Ile55Met), rs199645805, ClinGen CA4548196, cosmic curated COSV57447, ClinVar RCV000520518, REVEL 0.35, CADD 22.80, Conflicting interpretations, not provided; Weaver syndrome
- I55T (p.Ile55Thr), cosmic curated COSV10453
- Q58* (p.Gln58Ter), cosmic curated COSV57457
- E59* (p.Glu59Ter), NCI-TCGA Cosmic COSV5744, cosmic curated COSV57448, Ensembl rs2129484994, Variant assessed as somatic; high impact.
- W60* (p.Trp60Ter), cosmic curated COSV57464, Ensembl rs2129484989
- K61R (p.Lys61Arg), rs2537876792, ClinGen CA369708214, ClinVar RCV003457524, ClinVar RCV005100118, Uncertain significance, Weaver syndrome; not provided
- Q62* (p.Gln62Ter), cosmic curated COSV57459, Ensembl rs2129484985
- R63* (p.Arg63Ter), cosmic curated COSV57459, Ensembl rs2129484980, CADD 38.00
- R64M (p.Arg64Met), NCI-TCGA Cosmic COSV5744, cosmic curated COSV57445, Ensembl rs2129484976, Variant assessed as somatic; moderate impact.
- I65V (p.Ile65Val), cosmic curated COSV57447
- Q66R (p.Gln66Arg), cosmic curated COSV57461
- P67H (p.Pro67His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P67T (p.Pro67Thr), cosmic curated COSV57465
- I70V (p.Ile70Val), rs2537872876, ClinGen CA369708155, ClinVar RCV003611490, REVEL 0.28, CADD 17.70, Uncertain significance, Weaver syndrome
- L71M (p.Leu71Met), cosmic curated COSV10453
- S76* (p.Ser76Ter), cosmic curated COSV57462, TOPMed rs1814072463, CADD 39.00
- R78C (p.Arg78Cys), rs141583753, ClinGen CA4548189, cosmic curated COSV10023, ClinVar RCV001050174, REVEL 0.43, CADD 23.60, Benign, Weaver syndrome
- R78H (p.Arg78His), rs1218303603, ClinGen CA369708103, NCI-TCGA Cosmic COSV5745, cosmic curated COSV57452, REVEL 0.47, CADD 24.20, Benign, Weaver syndrome
- G79E (p.Gly79Glu), cosmic curated COSV10966, Ensembl rs2129484914
- R81S (p.Arg81Ser), cosmic curated COSV10023
- S84L (p.Ser84Leu), rs1182369323, ClinGen CA369707333, cosmic curated COSV57459, ClinVar RCV001967091, REVEL 0.37, CADD 24.50, Likely benign, Weaver syndrome
- V85A (p.Val85Ala), cosmic curated COSV10966, REVEL 0.66, CADD 24.50
- T86I (p.Thr86Ile), cosmic curated COSV10647
- D88Y (p.Asp88Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F91L (p.Phe91Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P92L (p.Pro92Leu), cosmic curated COSV57464, REVEL 0.49, CADD 23.80
- Q94* (p.Gln94Ter), cosmic curated COSV10610
- Q94E (p.Gln94Glu), cosmic curated COSV10441, gnomAD rs1319998961, REVEL 0.69, CADD 24.90
- Q94R (p.Gln94Arg), cosmic curated COSV57460
- V95G (p.Val95Gly), rs2537322826, ClinGen CA369707261, ClinVar RCV002653558, REVEL 0.51, CADD 23.20, Uncertain significance, Weaver syndrome
- P97S (p.Pro97Ser), cosmic curated COSV10582, TOPMed rs1228980656, gnomAD rs1228980656, REVEL 0.61, CADD 23.40
- L98S (p.Leu98Ser), cosmic curated COSV57446, REVEL 0.78, CADD 26.80
- K99N (p.Lys99Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N102S (p.Asn102Ser), cosmic curated COSV57459, Ensembl rs999855448
- A103V (p.Ala103Val), cosmic curated COSV57447
- I109* (p.Ile109Ter), cosmic curated COSV57446
- S112Y (p.Ser112Tyr), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Variant assessed as somatic; moderate impact.
- W113* (p.Trp113Ter), cosmic curated COSV57451, Ensembl rs2129478053
- S114F (p.Ser114Phe), cosmic curated COSV57451
- P115L (p.Pro115Leu), cosmic curated COSV10733, REVEL 0.82, CADD 27.00
- P115S (p.Pro115Ser), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, REVEL 0.73, CADD 22.60, Variant assessed as somatic; moderate impact.
- L116P (p.Leu116Pro), cosmic curated COSV57452, REVEL 0.87, CADD 28.70
- Q118H (p.Gln118His), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, REVEL 0.58, CADD 23.70, Variant assessed as somatic; moderate impact.
- M121I (p.Met121Ile), cosmic curated COSV10610, cosmic curated COSV57461, Ensembl rs2129478049, NCI-TCGA Cosmic COSV5744, REVEL 0.72, CADD 32.00, Variant assessed as somatic; moderate impact.
- D124N (p.Asp124Asn), NCI-TCGA TCGA novel, Ensembl rs2129477031, Variant assessed as somatic; moderate impact.
- E125K (p.Glu125Lys), cosmic curated COSV10610, Ensembl rs2129477025
- E125V (p.Glu125Val), cosmic curated COSV57449, Ensembl rs2129477024
- V127F (p.Val127Phe), cosmic curated COSV57446, Ensembl rs2129477018
- V127G (p.Val127Gly), rs2129477017, ClinGen CA369721862, ClinVar RCV004542645, AlphaMissense 1.00, MetaLR 0.71, Uncertain significance, EZH2-related disorder
- V127L (p.Val127Leu), cosmic curated COSV57458, Ensembl rs2129477018
- L128S (p.Leu128Ser), cosmic curated COSV10610
- H129D (p.His129Asp), cosmic curated COSV10453, 1000Genomes rs189454324, ExAC rs189454324, gnomAD rs189454324
- H129Q (p.His129Gln), cosmic curated COSV57463, Ensembl rs2129477010
- H129R (p.His129Arg), rs2129477011, ClinGen CA369721845, cosmic curated COSV57460, ClinVar RCV001775264, REVEL 0.74, CADD 22.90, Conflicting interpretations, Weaver syndrome
- I131F (p.Ile131Phe), cosmic curated COSV57455, Ensembl rs2129477005
- I131L (p.Ile131Leu), cosmic curated COSV10733
- I131N (p.Ile131Asn), cosmic curated COSV57464
- I131S (p.Ile131Ser), cosmic curated COSV10453, Uncertain significance, Weaver syndrome
- P132A (p.Pro132Ala), cosmic curated COSV10610, Ensembl rs193921148, Pathogenic, in WVS
- P132R (p.Pro132Arg), cosmic curated COSV10610
- P132S (p.Pro132Ser), rs193921148, ClinGen CA369721814, ClinVar RCV003887446, UniProt VAR 067595, AlphaMissense 1.00, MetaLR 0.84, Pathogenic, Weaver syndrome
- P132T (p.Pro132Thr), NCI-TCGA Cosmic COSV5745, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57463, REVEL 0.92, CADD 23.60, Likely pathogenic, not provided
- Y133C (p.Tyr133Cys), rs1808822115, ClinGen CA369721796, cosmic curated COSV10023, ClinVar RCV001201666, AlphaMissense 1.00, MetaLR 0.80, Pathogenic/Likely pathogenic, not provided; Weaver syndrome
- Y133D (p.Tyr133Asp), rs2537200779, ClinGen CA369721802, ClinVar RCV003147144, Uncertain significance, Weaver syndrome
- Y133H (p.Tyr133His), cosmic curated COSV57463
- Y133N (p.Tyr133Asn), cosmic curated COSV57456
- M134K (p.Met134Lys), cosmic curated COSV57465
- M134T (p.Met134Thr), cosmic curated COSV57453, UniProt VAR 078321, Pathogenic, in WVS
- G135E (p.Gly135Glu), cosmic curated COSV57457, Ensembl rs2129476993
- G135R (p.Gly135Arg), cosmic curated COSV57454, Ensembl rs2129476995
- D136G (p.Asp136Gly), cosmic curated COSV10588
- D136Y (p.Asp136Tyr), cosmic curated COSV10610
- D140H (p.Asp140His), cosmic curated COSV10884, Ensembl rs2129476972
- D140N (p.Asp140Asn), cosmic curated COSV57466, Ensembl rs2129476972
- Q141* (p.Gln141Ter), NCI-TCGA TCGA novel, Ensembl rs2129476967, Variant assessed as somatic; high impact.
- D142V (p.Asp142Val), NCI-TCGA Cosmic COSV5745, cosmic curated COSV57451, Ensembl rs2129476960, Variant assessed as somatic; moderate impact.
- D142Y (p.Asp142Tyr), cosmic curated COSV99053
- F145C (p.Phe145Cys), NCI-TCGA Cosmic COSV5744, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57463, Likely pathogenic, not provided
- F145L (p.Phe145Leu), cosmic curated COSV57459, cosmic curated COSV10453, Ensembl rs2129476942
- F145S (p.Phe145Ser), cosmic curated COSV57447
- F145Y (p.Phe145Tyr), NCI-TCGA Cosmic COSV5744, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57463, Variant assessed as somatic; moderate impact.
- I146N (p.Ile146Asn), cosmic curated COSV57459, Ensembl rs2129476940
- I146T (p.Ile146Thr), rs2129476940, cosmic curated COSV57462, ClinGen CA369721544, ClinVar RCV002931950, REVEL 0.79, CADD 23.60, Uncertain significance, Weaver syndrome
- E147K (p.Glu147Lys), cosmic curated COSV10520, Ensembl rs2129476936, REVEL 0.69, CADD 23.20
- E148* (p.Glu148Ter), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57465, Ensembl rs1808814702, Uncertain significance
- L149P (p.Leu149Pro), rs2129476923, ClinGen CA369721498, cosmic curated COSV57462, ClinVar RCV004534263, AlphaMissense 1.00, MetaLR 0.83, Uncertain significance, EZH2-related disorder
- L149Q (p.Leu149Gln), cosmic curated COSV57454, Ensembl rs2129476923, Uncertain significance
- L149R (p.Leu149Arg), cosmic curated COSV10023
- I150T (p.Ile150Thr), cosmic curated COSV57454
- I150V (p.Ile150Val), cosmic curated COSV10453
- K151E (p.Lys151Glu), NCI-TCGA Cosmic COSV5745, Variant assessed as somatic; moderate impact.
- K151Q (p.Lys151Gln), cosmic curated COSV57456
- N152I (p.Asn152Ile), NCI-TCGA Cosmic COSV1002, Variant assessed as somatic; high impact.
- N152S (p.Asn152Ser), cosmic curated COSV10023
- Y153C (p.Tyr153Cys), rs797044844, ClinGen CA347376, cosmic curated COSV57449, ClinVar RCV000193211, REVEL 0.93, CADD 26.90, not provided, Weaver syndrome
- G155R (p.Gly155Arg), cosmic curated COSV57461, Ensembl rs2129476910
- K156E (p.Lys156Glu), UniProt VAR 078322, Pathogenic, in WVS
- G159R (p.Gly159Arg), cosmic curated COSV10647, gnomAD rs1488870104, cosmic curated COSV57455, REVEL 0.74, CADD 26.30
- G159W (p.Gly159Trp), cosmic curated COSV10647
- D160A (p.Asp160Ala), cosmic curated COSV10441
- R161I (p.Arg161Ile), NCI-TCGA Cosmic COSV5746, Ensembl rs2129476871, Variant assessed as somatic; moderate impact.
- R161T (p.Arg161Thr), cosmic curated COSV57460, Ensembl rs2129476871
- E162* (p.Glu162Ter), NCI-TCGA Cosmic COSV1002, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57461, Ensembl rs2129476866, Variant assessed as somatic; high impact.
- E162K (p.Glu162Lys), cosmic curated COSV10023, Ensembl rs2129476866
- N167K (p.Asn167Lys), cosmic curated COSV10453
- E169D (p.Glu169Asp), NCI-TCGA Cosmic COSV5744, cosmic curated COSV57446, Variant assessed as somatic; moderate impact.
- I170L (p.Ile170Leu), cosmic curated COSV10441
- F171S (p.Phe171Ser), cosmic curated COSV57446
- V172A (p.Val172Ala), rs2537149561, ClinGen CA369720654, ClinVar RCV003001890, REVEL 0.67, CADD 24.10, Uncertain significance, Weaver syndrome
- V172C (p.Val172Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V172M (p.Val172Met), cosmic curated COSV10588, REVEL 0.56, CADD 24.90
- E173Q (p.Glu173Gln), cosmic curated COSV57458
- L174F (p.Leu174Phe), cosmic curated COSV57449
- G179S (p.Gly179Ser), rs1808496051, ClinGen CA369720565, ClinVar RCV003612410, AlphaMissense 0.53, MetaLR 0.25, Uncertain significance, Weaver syndrome
- Y181C (p.Tyr181Cys), cosmic curated COSV57448
- Y181S (p.Tyr181Ser), cosmic curated COSV10023
- N182K (p.Asn182Lys), cosmic curated COSV10610
- D183E (p.Asp183Glu), rs2537146396, cosmic curated COSV57465, ClinGen CA369720485, ClinVar RCV003613098, REVEL 0.36, CADD 17.00, Uncertain significance, Weaver syndrome
- D183Y (p.Asp183Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D183G (p.Asp183Gly), rs867587253, []
- D185G (p.Asp185Gly), cosmic curated COSV57451
- D185H (p.Asp185His), rs2302427, ClinGen CA159195, cosmic curated COSV57449, ClinVar RCV000120897, REVEL 0.45, CADD 24.80, Benign, not specified; not provided; Weaver syndrome
- D186N (p.Asp186Asn), rs1263098237, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, TOPMed rs1263098237, REVEL 0.39, CADD 23.30, Variant assessed as somatic; moderate impact.
- D188N (p.Asp188Asn), rs1585021829, ClinGen CA369720381, cosmic curated COSV57451, ClinVar RCV000810542, AlphaMissense 0.15, MetaLR 0.79, Uncertain significance, Weaver syndrome
- D189N (p.Asp189Asn), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, Ensembl rs2129476425, Variant assessed as somatic; moderate impact.
- D189H (p.Asp189His), cosmic curated COSV10610
- G190* (p.Gly190Ter), cosmic curated COSV10813, CADD 38.00
- D192N (p.Asp192Asn), rs778968366, ClinGen CA4548099, cosmic curated COSV57451, ClinVar RCV001216815, REVEL 0.18, CADD 21.40, Likely benign, Weaver syndrome
- D192Y (p.Asp192Tyr), cosmic curated COSV57452
- P193L (p.Pro193Leu), cosmic curated COSV10733, REVEL 0.22, CADD 22.00
- P193S (p.Pro193Ser), cosmic curated COSV10733
- E197* (p.Glu197Ter), cosmic curated COSV57465
- K199N (p.Lys199Asn), cosmic curated COSV57449
- K199T (p.Lys199Thr), cosmic curated COSV57453
- K201E (p.Lys201Glu), cosmic curated COSV10520
Public EZH2 analysis runs
- EZH2 analysis run — EZH2 (850 variants) — completed 2026-08-18